ASCERTAIN NEWSLETTER 3

ASCERTAIN NEWSLETTER 3

Dear readers, At the 4th ASCERTAIN Consortium meeting, held during the European Hematology Association (EHA) Congress in Madrid, we reached an important milestone by presenting 1.5 years of progress to our international advisory board. Our discussions centered around...
“3 Things About Market Access” – The First Video in Our Series!

Insights from Recent Site Visits in Norway

Recent site visits have highlighted the dynamic and collaborative efforts of the ASCERTAIN project in advancing precision cancer medicine (PCM) and health technology assessments (HTA) in Norway. On April 12th, PhD student Yancy S Wu presented initial findings from our...